EUVIMEDEUVIMED entdecken
Crossref

Prior GLP‐1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity‐matched analysis

Albert K Park iD, Jason Hom, Javier Lorenzo, Vidya Rao, Gavin Hui, Matthew Vickers, Neera Ahuja

Journal of Hospital Medicine · 2025

DOI: 10.1002/jhm.70228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hospital Medicine, 2025. Verfasst von Albert K Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stanford University Medical Center, Stanford, California, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Critical Care Outcomes, Critical Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucagon‐like peptide‐1 (GLP‐1) agonists are increasingly prescribed for obesity and type 2 diabetes. GLP‐1 agonists influence body composition through effects on both fat mass and fat‐free mass. Given that critically ill patients experience severe protein catabolism and commonly develop intensive care unit (ICU)‐acquired weakness, questions arise about outcomes when metabolic demands are high during critical illness.

Objective

The objective of this study is to examine the relationship between prior GLP‐1 agonist use and critical care outcomes.

Methods

We conducted a retrospective cohort study using Stanford Health Care data from January 2015 to July 2024. Adults aged 18–89 years admitted to intensive care with body mass index (BMI) 20–60 kg/m 2 were included. Of 15,191 eligible ICU patients, 468 (3.1%) received GLP‐1 agonist prescriptions within 12 months before hospitalization. Using high‐dimensional propensity score matching with lasso regression, we created 452 matched pairs and compared in‐hospital mortality, hospital length of stay, and ICU length of stay between groups.

Results

Baseline characteristics were well‐balanced. The matched GLP‐1 agonist and comparison groups showed similar in‐hospital mortality (5.1% vs. 4.9%, odds ratio [OR]: 1.05, 95% confidence interval [CI]: 0.58 to 1.91, p = .88), mean hospital length of stay (13.7 ± 21.3 vs. 13.4 ± 18.1 days, mean difference [MD]: 0.38, 95% CI: −2.21 to 3.05, p = .77), and ICU length of stay (5.9 ± 9.0 vs. 5.4 ± 6.6 days, MD: 0.51, 95% CI: –0.52 to 1.50, p = .33).

Conclusions

In this first study examining the relationship between prior GLP‐1 agonist use and critical care outcomes, we found no significant associations with in‐hospital mortality, hospital length of stay, or ICU length of stay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide 1Critical Care OutcomesCritical CareHumansFemaleMaleRetrospective StudiesMiddle AgedAgedHospital MortalityPropensity ScoreLength of StayIntensive Care UnitsAged, 80 and overAdultCritical IllnessGlucagon-Like Peptide-1 Receptor Agonists

Substanzen

Glucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Medicine, Stanford University Medical Center, Stanford, California, USA.
  • Department of Anesthesiology, Perioperative and Pain Medicine, Division of Anesthesia Critical Care, Stanford University Medical Center, Stanford, California, USA.
  • Atropos Health, Palo Alto, California, USA.
  • Eucalyptus, Sydney, Australia.

ORCID-Profile: Albert K Park

Förderung

  • None

Zitieren

APA

Park, A. K., Hom, J., Lorenzo, J., Rao, V., Hui, G., Vickers, M., & Ahuja, N. (2025). Prior GLP‐1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity‐matched analysis. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.70228

Vancouver

Park AK, Hom J, Lorenzo J, Rao V, Hui G, Vickers M, et al. Prior GLP‐1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity‐matched analysis. Journal of Hospital Medicine. 2025. doi:10.1002/jhm.70228

BibTeX
@article{Park2025,
  author = {Park, Albert K and Hom, Jason and Lorenzo, Javier and Rao, Vidya and Hui, Gavin and Vickers, Matthew and Ahuja, Neera},
  title = {Prior GLP‐1 agonist use is not associated with adverse inpatient critical care outcomes: A propensity‐matched analysis},
  journal = {Journal of Hospital Medicine},
  year = {2025},
  doi = {10.1002/jhm.70228}
}
Kostenlos starten →